To elucidate the mechanisms of inhibition of CYP2A6 and CYP2B6 by (−)-POH and (−)-PAH, their metabolism-dependent inhibition potentials were investigated (Figure 2). Here, CYP2B6 is linked to pulmonary arterial hypertension.